On June 2, 2021 Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that Chief Executive Officer Saiid Zarrabian will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021 (Press release, Kintara Therapeutics, JUN 2, 2021, View Source [SID1234583382]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Zarrabian will deliver his corporate presentation on June 9 at 2:30 pm ET, Track 1.

Register to watch the presentation here.

Investors interested in scheduling a meeting with management should contact [email protected].